Bioventix (LON:BVXP) Share Price Crosses Below 200 Day Moving Average – Should You Sell?

Shares of Bioventix PLC (LON:BVXPGet Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 3,865.74 ($47.30) and traded as low as GBX 3,050 ($37.32). Bioventix shares last traded at GBX 3,250 ($39.77), with a volume of 4,369 shares.

Bioventix Stock Down 4.3 %

The business has a 50-day moving average price of GBX 3,505.18 and a 200-day moving average price of GBX 3,865.74. The firm has a market capitalization of £162.34 million, a price-to-earnings ratio of 1,907.98 and a beta of 0.35.

Bioventix Increases Dividend

The firm also recently declared a dividend, which was paid on Thursday, November 21st. Stockholders of record on Thursday, November 7th were given a dividend of GBX 87 ($1.06) per share. The ex-dividend date of this dividend was Thursday, November 7th. This is an increase from Bioventix’s previous dividend of $68.00. This represents a dividend yield of 2.4%. Bioventix’s dividend payout ratio is presently 9,693.25%.

Insider Transactions at Bioventix

In other news, insider Bruce Hiscock bought 300 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The shares were purchased at an average cost of GBX 3,330 ($40.74) per share, with a total value of £9,990 ($12,223.17). Over the last three months, insiders have acquired 385 shares of company stock valued at $1,107,381. Corporate insiders own 8.02% of the company’s stock.

About Bioventix

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.

Read More

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.